CLINICAL RESEARCH: ENDOTHELIAL FUNCTION
Family History of Diabetes Is a Major Determinant of Endothelial Function
Allison B. Goldfine, MD*,
,*,
Joshua A. Beckman, MD,
Rebecca A. Betensky, PhD
,
Heather Devlin*,
Shauna Hurley,
Nerea Varo, PhD,2,
Uwe Schonbeck, PhD,3,
Mary Elizabeth Patti, MD* and
Mark A. Creager, MD,1
* Joslin Diabetes Center, Boston, Massachusetts
Brigham and Women’s Hospital, Boston, Massachusetts
Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts.
Manuscript received October 18, 2005;
revised manuscript received February 1, 2006,
accepted February 14, 2006.
* Reprint requests and correspondence: Dr. Allison B. Goldfine, Joslin Diabetes Center, One Joslin Place, Boston, Massachusetts 02215. (Email: allison.goldfine{at}joslin.harvard.edu).
 |
Abstract
|
|---|
OBJECTIVES: We evaluated whether endothelial dysfunction was present in nondiabetic persons with a family history (FH) of diabetes and assessed its relationship with insulin resistance and atherosclerosis risk factors.
BACKGROUND: Atherosclerosis is frequently present when type 2 diabetes (T2D) is first diagnosed. Endothelial dysfunction contributes to atherogenesis.
METHODS: Oral glucose tolerance and brachial artery flow-mediated, endothelium-dependent vasodilation (EDV) were assessed in 38 nondiabetic subjects; offspring of two parents with T2D (FH+) or with no first-degree relative with diabetes (FH–).
RESULTS: Although fasting glucose was higher in FH+ than FH– (5.3 ± 0.1 mmol/l vs. 4.9 ± 0.1 mmol/l, p < 0.03), glycemic burden assessed as 2-h or area-under-the-curve glucose after glucose load or glycosylated hemoglobin (HbA1c), and measures of insulin sensitivity or inflammation did not differ. Brachial artery flow-mediated EDV was reduced in FH+ (7.1 ± 0.9% vs. 11.7 ± 1.6%, p < 0.02), with no difference in nitroglycerin-induced endothelium-independent vasodilatation. In the combined cohort, only FH+ (r2 = 0.12, p < 0.02) and HbA1c (r2 = 0.14, p < 0.02) correlated with EDV. Insulin resistance, assessed by tertile of homeostasis model assessment of insulin resistance (HOMA-IR), was associated with impaired endothelium-dependent vasodilatation in FH– (p < 0.03, analysis of variance), but not in FH+, as even the most insulin-sensitive FH+ offspring had diminished endothelial function. In multiple regression analysis, including established cardiac risk factors, blood pressure and lipids, HbA1c, and HOMA-IR, FH remained a significant determinant of EDV (p = 0.04).
CONCLUSIONS: Bioavailability of nitric oxide is lower in persons with a strong FH of T2D. Glycemic burden, even in the nondiabetic range, can contribute to endothelial dysfunction. Abnormalities of endothelial function may contribute to atherosclerosis before development of overt diabetes.
|
Abbreviations and Acronyms
| | EDV = endothelium-dependent vasodilation | | EIV = endothelium-independent vasodilation | | FH = family history | | FH+ = subjects with both parents having type 2 diabetes | | FH– = subjects with no first-degree relative with diabetes or coronary artery disease | | HbA1c = glycosylated hemoglobin | | HOMA-IR = homeostasis model assessment of insulin resistance | | T2D = type 2 diabetes |
|
Cardiovascular disease is the leading cause of morbidity and mortality for patients with diabetes. Atherosclerosis is frequently present on diagnosis of type 2 diabetes (T2D), suggesting atherosclerotic processes begin before the onset of overt diabetes. Insulin resistance is highly associated with T2D, hypertension, dyslipidemia, obesity, and cardiovascular disease. Insulin resistance precedes and predicts both incident diabetes and cardiovascular disease. However, recent studies suggest insulin resistance per se may impart greater risk for development of diabetes in offspring of two parents with T2D than in persons with no family history (FH) of disease (1). Whether insulin resistance imparts increased cardiovascular risk in persons with a strong FH of diabetes remains unknown.
The endothelium participates in atherosclerotic pathogenesis. Attenuated function is considered an early marker of vascular disease. Although some studies demonstrated endothelial dysfunction in persons with FH of diabetes (2,3), this remains controversial (4). We hypothesized that vascular function among offspring of parents with diabetes is abnormal compared with persons with no FH of diabetes or coronary artery disease, even when traditional cardiac risk factors are similar. We characterized inter-relationships among insulin resistance, cardiac risk factors, and endothelial function according to FH of diabetes.
|
Methods
|
|---|
The study was approved by the institutional review board. Thirty-eight nondiabetic healthy subjects, 19 with two T2D parents (FH+) and 19 with no first-degree relative with diabetes or coronary artery disease (FH–), provided written informed consent. Family history was defined during medical interview by participant report of either diabetes in both biological parents (FH+), or in neither biological parent or any first-degree relative (FH –). The FH+ cohort has been previously described (5). The FH– cohort were recruited to be similar for age, gender, and body mass index. All were normotensive and non-smokers.
Fasting lipids and oral glucose tolerance, using a 100-g glucose load to maximize glucose and insulin excursion, were evaluated. Subjects were deemed nondiabetic using National Diabetes Data Group criteria (6,7). Areas under the curve for glucose and insulin were calculated by triangulation, and insulin resistance was determined by homeostasis model assessment (HOMA-IR).
Vascular function studies.
Endothelial function was determined using high-resolution ultrasonography (Toshiba Powervision 8000, 7.5 MHz linear-array probe, Toshiba America Medical Systems, Inc., Tustin, California) triggered by electrocardiogram "R" wave with Data Translation frame-grabber videocard (Dataviz, Trumbull, Connecticut) as previously described (5). A sphygmomanometric cuff placed above the antecubital fossa was inflated to suprasystolic pressure for 5 min. Flow-induced, endothelial-dependent vasodilation (EDV) was determined 1 min after cuff deflation. Endothelium-independent vasodilation (EIV) was determined 3 min after nitroglycerin, 0.4 mg sublingually, which was withheld for systolic blood pressure <100 mm Hg (four subjects in each group). Arterial diameter was measured using edge detection software (Brachial Tools 4.2.2, Medical Imaging Applications LLC, Iowa City, Iowa).
Assays.
Glucose, lipids, and glycohemoglobin were measured in the Joslin clinical laboratory. Immunoassays were performed in duplicate and included serum insulin (Diagnostic Systems Laboratories, Webster, Texas), high-sensitivity C-reactive protein (Alpha Diagnostic International, San Antonio, Texas), interleukin-6 (R&D Systems, Inc., Minneapolis, Minnesota), FFA (Wako Chemicals Inc., Richmond, Virginia), plasma plasminogen activator inhibitor-1 (American Diagnostica, Greenwich, Connecticut), soluble intercellular adhesion molecule-1 (R&D Systems), soluble CD40 ligand (BenderMedSystems, Vienna, Austria), and adiponectin (Linco Research, Inc., St. Charles, Missouri).
Statistical analysis.
The unpaired t test was used for comparison of FH+ and FH–. Pearson’s correlation, analysis of variance (ANOVA), and simple, stepwise, and multiple regression analyses were performed using StatView (SAS Institute Inc., Cary, North Carolina). Independent variables were assessed directly and after logarithmic transformation for skewed distribution. Because no data became uniquely significant after logarithmic transformation, all data are presented as natural variables. Results are considered significant with two-tailed p values <0.05.
|
Results
|
|---|
Study subjects.
No subject had diabetes. Glycosylated hemoglobin (HbA1c) was within normative range (4% to 6%) in all participants. Ten subjects in each group had 2-h glucose concentrations between 7.8 to 11.1 mmol/l, suggesting some glucose intolerance. Demographic and metabolic characteristics are summarized (Table 1). Although fasting glucose was higher in FH+ than FH– (5.3 ± 0.1 mmol/l vs. 4.9 ± 0.1 mmol/l, respectively, p < 0.03), no significant differences existed in all other measures of glycemia including 2-h glucose, area-under-the-curve glucose, or HbA1c. Plasminogen activator inhibitor-1 tended to be higher in FH+ (p = 0.07), largely due to one FH+ subject. All other metabolic and inflammatory measures did not differ between groups.
EDV and FH of diabetes.
Endothelium-dependent vasodilation was 38% lower in FH+ than FH– (7.1 ± 0.9% vs. 11.7 ± 1.6%, p < 0.02). There was no difference between groups in EIV (18.9 ± 1.3% vs. 18.3 ± 1.7%, p = 0.8) (Fig. 1). Baseline diameter of the brachial artery was similar (3.6 ± 0.2 mm vs. 3.5 ± 0.1 mm, p = 0.8, FH+ vs. FH–, respectively).
View larger version (14K):
[in this window]
[in a new window]
|
Figure 1 Endothelium-dependent vasodilatation is impaired in offspring of two diabetic parents (FH+) compared to with persons without family history of diabetes (FH–). Endothelium-independent vasodilatation is not impaired.
|
|
EDV and insulin resistance.
To assess the relationship between HOMA-IR and EDV, the entire cohort was divided into tertiles of insulin resistance (<1.3, 1.3 to 2.6, and >2.6). In two-way ANOVA, FH remained an important determinant of EDV (p = 0.03). There was no difference in EDV in the two most insulin-sensitive subgroups, but the most resistant tertile had significantly lower EDV (Fig. 2). The same boundary levels of HOMA-IR were then applied to FH+ and FH–; thus, groups were similar in magnitude of insulin resistance. Each tertile was represented in FH+ and FH–. The same pattern was seen for insulin resistance and EDV in FH– as in the whole cohort. Specifically, the most insulin-resistant persons had abnormal EDV. However, in FH+, EDV was impaired in all three tertiles of insulin sensitivity, and there was no relationship between EDV and HOMA-IR. Similar relationships were obtained using a general linear model analysis with HOMA-IR and FH as covariates, accounting for multiple comparisons.
View larger version (42K):
[in this window]
[in a new window]
|
Figure 2 The whole cohort was divided into tertiles of homeostasis model assessment of insulin resistance (HOMA-IR), such that the lowest tertile is most insulin sensitive and the highest tertile most resistant. The same levels of HOMA-IR were then applied to define the subgroups within positive family history (FH+) and negative family history (FH–) groups. There was reduced endothelium-dependent vasodilation (EDV) in the most resistant persons of the whole cohort, and in the most insulin-resistant FH– group as compared to with either of the two more sensitive subgroups; however, there was no relationship between HOMA-IR and EDV in FH+, such that even the most insulin-sensitive offspring had attenuated EDV. *p < 0.05.
|
|
Although insulin resistance was demonstrated to interact with endothelial function, HOMA-IR associated more strongly with traditional cardiac risk factors, obesity, cholesterol, and blood pressure than with EDV (Table 2). Using Bonferroni correction for multiple comparisons, correlations between HOMA-IR and measures of obesity, high-density lipoprotein, and triglycerides remained significant.
EDV and glycemic burden.
In secondary analysis evaluating glycemia and traditional cardiac risk factors with endothelial function, relationships between EDV, FH, and each metabolic variable were evaluated using simple regression analysis. In the combined cohort, only FH (r2 = 0.12, p < 0.02) and HbA1c (r2 = 0.14, p < 0.02) correlated inversely with EDV (Fig. 3), suggesting an important interaction between chronic glycemia and EDV, even in the normative range.
View larger version (15K):
[in this window]
[in a new window]
|
Figure 3 Simple linear regression is demonstrated between endothelium-dependent vasodilatation (EDV) and glycosylated hemoglobin (HbA1c), demonstrating within normal range higher glycemic burden associates with attenuated EDV. Individual data are presented for subjects with a family history of diabetes (FH+) (solid circles) and subjects without a family history of diabetes (FH–) (open circles).
|
|
Next, we evaluated FH+ and FH– subgroups independently. In FH–, HbA1c (r2 = 0.15, p = 0.05), cholesterol (r2 = 0.38, p < 0.005), and systolic blood pressure (r2 = 0.23, p < 0.04) each correlated inversely with EDV. In FH+, only high-density lipoprotein directly associated with EDV (r2 = 0.31, p < 0.02), as previously reported (5). In contrast with FH–, there was no association between EDV and cholesterol or systolic blood pressure in FH+; EDV was attenuated across the normative range of these variables (Fig. 4). Although significant relationships might become evident with larger cohorts, these data suggest the strength of the relationship between EDV and traditional cardiac risk factors may differ in FH+ and FH–. Furthermore, FH+ demonstrate blunted endothelial function across the range of cholesterol and systolic pressure, suggesting protective benefits of low blood pressure or low cholesterol on EDV is attenuated in FH+.
View larger version (31K):
[in this window]
[in a new window]
|
Figure 4 Simple linear regression is demonstrated with endothelium-dependent vasodilation as the dependent variable and cholesterol high-density lipoprotein (HDL) and systolic blood pressure (BP) as independent variables in subjects with a family history of diabetes (FH+) and subjects without a family history of diabetes (FH–). Individual data are presented for FH+ (solid circles) and FH– (open circles). Positive family history subjects demonstrate blunted endothelial dilation across the range of cholesterol and systolic pressure.
|
|
In multiple regression analysis of the entire cohort, incorporating only independent variables significantly correlated in the whole cohort or in either FH+ or FH– subgroups (FH, HbA1c, HOMA-IR, cholesterol, high-density lipoprotein cholesterol, and systolic blood pressure); only FH (p = 0.04) remained a significant determinant of EDV. We fit bivariate models with FH and each major cardiac risk factor as predictors, along with their interaction with FH and found significant interactions between FH and both cholesterol (p = 0.004) and systolic blood pressure (p = 0.03). Additionally, the main effects of the risk factors of cholesterol and blood pressure were significant (p = 0.0009 and p = 0.01, respectively) as was FH status (p < 0.01 in each model), indicating they are indeed independently predictive of EDV even in the presence of FH, and that FH is an independent predictor of EDV. These data suggest adverse effects of FH on EDV are mediated in part, but not solely, through blood pressure and lipids, even when these measures are normative. Due to differences in fasting glucose between groups, the analysis was repeated including fasting glucose in the model. Family history remained a significant determinant of EDV (p < 0.03).
Inflammation and endothelial function.
Relationships between EDV and inflammatory cytokine/adipokine measures of inflammatory mediators did not correlate with EDV in the whole cohort, or in either FH+ or FH– subgroups.
|
Discussion
|
|---|
Our study demonstrates reduced EDV in nondiabetic individuals with strong FH compared with persons with no FH of diabetes. Differences cannot be explained by confounding variables including age, gender, ethnicity, obesity, lipids, blood pressure, glycemia, or insulin resistance. Although we did not find associations between EDV and age or obesity previously reported in population-based studies (8), ranges of these variables were smaller in our healthy cohort. In multiple regression analysis, only FH remained a significant determinant of EDV. Furthermore, endothelial dysfunction was demonstrated in even the most insulin-sensitive offspring of diabetic parents. Although the pleiotropic metabolic disturbances of the pre-diabetic state may contribute additively or synergistically to atherosclerosis pathogenesis, our findings suggest a strong FH of diabetes is independently associated with diminished EDV and may contribute to cardiovascular risk in advance of overt diabetes. Frequent presence of vascular pathology at the time of diagnosis of diabetes suggests importance for identification of pre-diabetic persons with diminished endothelial function and early atherosclerotic disease, and FH of diabetes is a recognized risk for development of diabetes.
Several previous investigations also found endothelial dysfunction in offspring of diabetic parents (2,3), though this remains controversial (4). In these studies, offspring cohorts differed from control subjects with respect to post-load glucose and insulin, cholesterol, severity of insulin resistance, body mass index, blood pressure, and other factors (2–4). Also, relationships between glucose metabolic clearance rate and endothelial function were not assessed in control subjects (3). These confounding differences make it difficult to assess independent effects of FH of diabetes on endothelial function. Our FH+ were offspring of two T2D parents, contrasting with studies with just one of two parents with diabetes, thereby enriching our group for familial differences. Moreover, our cohorts were similar for multiple confounding variables, yet attenuation of EDV was significant in offspring.
Hyperglycemia and endothelial function.
Both hyperglycemia and insulin resistance could contribute to atherosclerosis. In the absence of overt diabetes, multiple studies have found that either impaired fasting or 2-h post-load glucose predicts cardiovascular events (9,10). Fasting hyperglycemia diminishes microvascular hyperemia (11) and inversely correlates with EDV (8), and short-term hyperglycemia attenuates endothelial function in healthy persons (12). Hyperglycemia may adversely affect vascular function through multiple mechanisms including increased flux through the polyol pathway, increased oxidative stress, activation of protein kinase C-beta, and advanced-glycation end products formation (13). We evaluated nondiabetic cohorts with normal-to-mild glucose intolerance enriching our cohorts for risk of diabetes and early atherosclerotic pathology. This is the first study to document an association between normative HbA1c and EDV in nondiabetic persons further implicating an important and adverse effect of very mild elevations in glucose on endothelial function. All subjects had normative fasting glucose, yet differences in glycemic burden assessed by fasting glucose existed between groups. Therefore, we cannot discount the possibility that a marginal increase in blood glucose contributes to attenuation in endothelial function in offspring.
Insulin resistance and endothelial function.
Insulin resistance is associated with endothelial dysfunction, cardiovascular risk (14), and incident cardiovascular events in epidemiology studies (15). Although our sample size is small, we found insulin resistance associates with impaired EDV. The relationship was predominant in FH–, with diminished endothelial function in the most insulin-sensitive FH+ offspring. In Native Americans, another high-risk group for development of diabetes, HOMA-IR was predictive of incident diabetes but not predictive of incident cardiovascular disease after adjustment for established cardiac risk factors including body mass index, waist circumference, blood pressure, and lipids (16). Consistently, we demonstrate HOMA-IR is more strongly related to traditional cardiac risk factors than with EDV.
Subclinical inflammation is associated with insulin resistance (17) and cardiovascular disease (18). In our study, endothelial dysfunction in FH+ offspring was not reflected by differences in multiple inflammatory measures. Nonetheless, other cytokines/adipokines could underlie attenuated EDV in offspring.
Although insulin resistance precedes development of diabetes in high-risk cohorts including offspring of diabetic parents, Pima Indians, and other ethnic minority populations, (6,19,20) insulin resistance per se may not be sufficient for development of diabetes in Caucasian persons without FH of disease who are at lower risk (1). A FH of diabetes, therefore, may impart additional factor(s) permissive for progression to disease. As FH of diabetes remains significantly correlated with endothelial function, it is interesting to speculate whether similar environmental or genetic risk factor(s) not assessed in current measures underlies both endothelial dysfunction and predisposition to diabetes.
Conclusions.
We demonstrate that nondiabetic offspring of diabetic parents have impaired EDV. These data suggest bioavailability of nitric oxide is lower in offspring of two T2D parents and may contribute to cardiovascular risk in advance of development of overt diabetes. Modest hyperglycemia, even within the normative range, may contribute to attenuated endothelial function. Finally, as endothelial dysfunction is present in nondiabetic offspring of diabetic parents, strong FH of T2D could be considered an additional cardiac risk factor.
|
Footnotes
|
|---|
Supported by NIH P01 HL48743, K23-DK02795, P30 DK36836, M01 RR001032.
1 Dr. Creager is the Simon C. Fireman Scholar in Cardiovascular Medicine at Brigham and Women’s Hospital. 
2 Dr. Varo is now at Clinica Universitaria de Navarra, Pamplona, Spain.
3 Dr. Schonbeck is now with the Department of Cardiovascular Disease, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
|
References
|
|---|
- Goldfine AB, Bouche C, Parker RA, et al. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease Proc Natl Acad Sci U S A 2003;100:2724-2729.[Abstract/Free Full Text]
- Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes Diabetes 1999;48:1856-1862.[Abstract]
- Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance Circulation 2000;101:1780-1784.[Abstract/Free Full Text]
- Lee BC, Shore AC, Humphreys JM, et al. Skin microvascular vasodilatory capacity in offspring of two parents with type 2 diabetes Diabet Med 2001;18:541-545.[Medline]
- Halperin F, Beckman JA, Patti ME, et al. The role of total and high-molecular-weight complex of adiponectin in vascular function in offspring whose parents both had type 2 diabetes Diabetologia 2005;48:2147-2154.[CrossRef][ISI][Medline]
- Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitusresults of a 25-year follow-up study. Lancet 1992;340:925-929.[CrossRef][ISI][Medline]
- National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance Diabetes 1979;28:1039-1057.[ISI][Medline]
- Vita JA, Keaney Jr. JF, Larson MG, et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study Circulation 2004;110:3604-3609.[Abstract/Free Full Text]
- Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality Diabetologia 1999;42:1050-1054.[CrossRef][ISI][Medline]
- Balkau B, Shipley M, Jarrett RJ, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study Diabetes Care 1998;21:360-367.[Abstract]
- Jaap AJ, Hammersley MS, Shore AC, Tooke JE. Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 1994;37:214-216.[CrossRef][ISI][Medline]
- Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo Circulation 1998;97:1695-1701.[Abstract/Free Full Text]
- Brownlee M. Biochemistry and molecular cell biology of diabetic complications Nature 2001;414:813-820.[CrossRef][Medline]
- Hsueh WA, Quinones MJ. Role of endothelial dysfunction in insulin resistance Am J Cardiol 2003;9210–7J.
- Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular diseasethe San Antonio Heart Study. Diabetes Care 2002;25:1177-1184.[Abstract/Free Full Text]
- Resnick HE, Jones K, Ruotolo G, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indiansthe Strong Heart Study. Diabetes Care 2003;26:861-867.[Abstract/Free Full Text]
- Festa A, D’Agostino Jr. R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndromethe Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47.[Abstract/Free Full Text]
- Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation Circ Res 2001;89:763-771.[Abstract/Free Full Text]
- Lillioja S, Mott DM, Spraul M, et al. Prospective studies of Pima Indians Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus N Engl J Med 1993;329:1988-1992.[Abstract/Free Full Text]
- Osei K, Cottrell DA. Minimal model analyses of insulin sensitivity and glucose-dependent glucose disposal in black and white Americansa study of persons at risk for type 2 diabetes. Eur J Clin Invest 1994;24:843-850.[ISI][Medline]
This article has been cited by other articles:
|
|
|
|
 
I. Lekli, G. Szabo, B. Juhasz, S. Das, M. Das, E. Varga, L. Szendrei, R. Gesztelyi, J. Varadi, I. Bak, et al.
Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin
Am J Physiol Heart Circ Physiol,
February 1, 2008;
294(2):
H859 - H866.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Blouet, F. Mariotti, V. Mathe, D. Tome, and J.-F. Huneau
Nitric Oxide Bioavailability and Not Production Is First Altered During the Onset of Insulin Resistance in Sucrose-Fed Rats
Experimental Biology and Medicine,
December 1, 2007;
232(11):
1458 - 1464.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Valdez, K. J. Greenlund, M. J. Khoury, and P. W. Yoon
Is Family History a Useful Tool for Detecting Children at Risk for Diabetes and Cardiovascular Diseases? A Public Health Perspective
Pediatrics,
September 1, 2007;
120(SUPPLEMENT_2):
S78 - S86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. T. Bloomgarden
Insulin Resistance, Dyslipidemia, and Cardiovascular Disease
Diabetes Care,
August 1, 2007;
30(8):
2164 - 2170.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ceriello, L. Piconi, K. Esposito, and D. Giugliano
Telmisartan Shows an Equivalent Effect of Vitamin C in Further Improving Endothelial Dysfunction After Glycemia Normalization in Type 1 Diabetes
Diabetes Care,
July 1, 2007;
30(7):
1694 - 1698.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Beckman, A. B. Goldfine, A. Dunaif, M. Gerhard-Herman, and M. A. Creager
Endothelial Function Varies According to Insulin Resistance Disease Type
Diabetes Care,
May 1, 2007;
30(5):
1226 - 1232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ceriello, S. Kumar, L. Piconi, K. Esposito, and D. Giugliano
Simultaneous Control of Hyperglycemia and Oxidative Stress Normalizes Endothelial Function in Type 1 Diabetes
Diabetes Care,
March 1, 2007;
30(3):
649 - 654.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Hirata, A. Kadirvelu, M. Di Tullio, S. Homma, A. M. Choy, and C. C. Lang
Coronary Vasomotor Function Is Abnormal in First-Degree Relatives of Patients With Type 2 Diabetes
Diabetes Care,
January 1, 2007;
30(1):
150 - 153.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. H. Yeung, J. S. Pankow, B. C. Astor, N. R. Powe, C. D. Saudek, and W.H. L. Kao
Increased Risk of Type 2 Diabetes From a Family History of Coronary Heart Disease and Type 2 Diabetes
Diabetes Care,
January 1, 2007;
30(1):
154 - 156.
[Full Text]
[PDF]
|
|
|
Top
Abstract
Methods
